HomeEXECUTIVESMedin Technologies, Inc. Announces Appointment of Bob Baker as CEO

Medin Technologies, Inc. Announces Appointment of Bob Baker as CEO

Medin Technologies, Inc. a leading orthopedic industry contract manufacturer, announced that Bob Baker has joined the company as Chief Executive Officer and a member of its board of directors.

Bob Baker joins Medin with an accomplished background in strategic, commercial and operational leadership in the orthopedic industry, having most recently served as Chief Executive Officer of Glebar Company, a leading manufacturer of advanced grinding machine systems for the medical device industry and other end markets. In his tenure at Glebar, Bob led a strategic transformation of the business, restructuring the company to address new market challenges, upgrading operations, and completing several strategic add-on acquisitions.

“I am honored to be joining Medin at such a pivotal moment for the orthopedic industry,” said Bob. “Demand for quality orthopedic products continues to increase as the market begins to address the backlog of elective procedures created by the global pandemic. Medin and AMT are well positioned to meet this global demand through optimized production and product diversification. This is an incredible opportunity and I look forward to working with this great team through the combined companies’ next phase of growth.”

“We are thrilled and excited to have Bob join the team as CEO for Medin and AMT,” said Mark Kammert, Partner of Seven Point Partners, LLC. “Bob has a proven track record in demonstrating outstanding leadership qualities and delivering exceptional value to customers. As Medin and AMT’s growth continues to accelerate in the post-COVID environment, we are confident that Bob is the right leader to expand market opportunity in medical contract manufacturing, while at the same time building on the company’s strong reputation for world class quality, product design, and customer responsiveness.”

Seven Point Partners LLC owns Medin Technologies and its sister company, AMT Medical, Inc.

“OEM customers in the medical device and orthopedic implant sector have necessarily high expectations in terms of quality, design and product delivery,” said Seven Point Managing Partner Tom Burchill. “Bob’s strong track record of commercial and operational excellence in the medical products industry is ideal to meet this need while simultaneously driving long-term revenue growth, profitability and outstanding outcomes for our valued customers.”

Prior to joining Glebar, Bob was Vice President, Operations at Stryker Corporation, in support of the Orthopedics Group. Previously, he was a Captain in the U.S. Army, serving in Iraq and Afghanistan.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.


"We are excited to welcome Jeff Anderson to Nutjobs as our new CEO. His broad experience and tactical leadership will be instrumental in executing against our vision to provide innovative, sustainable solutions to our customers," said Paul Kephart, Co-Founder, Chief Technology Officer and Chairperson of the Nutjobs Board.
Potrero Medical believes that this voluntary reorganization will bolster its finances and facilitate its ongoing focus on elevating patient care.
Dr John Parker will work closely with PeriGen's client base to optimize use of the company's analytics for patient care and research. He will also be instrumental in informing product development and regulatory affairs as PeriGen continues to expand its product suite and associated services.
“We’re delighted to welcome Gerald and Hannah to the PrecisionLife team at a time when our deep disease insights and patient stratification biomarkers are finding important new markets and bringing precision approaches to the early, more accurate diagnosis and care of patients with complex chronic diseases,” said Dr Steve Gardner, PrecisionLife CEO.
Broken String Biosciences reports Gavin Burns will be responsible for building and optimizing the companys teams, processes, and systems.

By using this website you agree to accept Medical Device News Magazine Privacy Policy